Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-08-17

Clinical Trial Update: Intermittent Neurogenic Claudication Treatment With APERIUS® [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for APERIUS addressing intermittent neurogenic claudication in spinal stenosis; results were posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • APERIUS

Snippet

Sponsor: Medtronic Spinal and Biologics | Conditions: Spinal Stenosis | Phase 4 | Status: COMPLETED | Results posted: 2011-08-17